Drug Trial Radar · NCT07474649
A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
103
Planned (sponsor's estimate)
Start
Sep 14, 2026
Primary completion
Jun 1, 2028
Study completion Oct 2, 2028
Sponsor
- Lead sponsor
- Daiichi SankyoDaiichi Sankyo (DSNKY)
- Sponsor type
- Industry
- First posted
- Mar 16, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall objective of the trial is to evaluate the effect of the triple therapy consisting of bempedoic acid (BA), ezetimibe (EZE), and high-intensity atorvastatin or rosuvastatin on changes in coronary plaque burden and plaque morphology in patients with coronary atherosclerosis without significant obstructive coronary artery disease and without prior history of an ischemic vascular event.
Conditions
- Coronary Atherosclerosis
- Mixed Dyslipidemia
- Hypercholesterolemia
Interventions
Bempedoic acidDrug
FDC: 180 mg
EzetimibeDrug
FDC: 10 mg
RosuvastatinDrug
20 mg dose
AtorvastatinDrug
40 mg dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualised change in percentage plaque burden (Δ%PB)Time frame: Baseline up to 12 months
Locations
12 sites in 3 countries. Site status is shown where the registry gives one.
Charité - Universitätsmedizin Berlin
Berlin, Germany · Not yet recruiting
UKE Hamburg
Hamburg, Germany · Not yet recruiting
Universität Mainz
Mainz, Germany · Recruiting
Heidelberg University
Mannheim, Germany · Not yet recruiting
IRCCS Policlinico San Donato
Milan, Italy · Not yet recruiting
Cardiology, IRCCS San Raffaele Scientific Institute
Milan, Italy · Not yet recruiting
AOU Federico II di Napoli
Naples, Italy · Not yet recruiting
IRCCS Ospedale Sacro Cuore - Don Calabria
Negrar, Italy · Not yet recruiting
Hospital Quironsalud Barcelona
Barcelona, Spain · Not yet recruiting
Hospital San Rafael
Madrid, Spain · Not yet recruiting
CUN (Clínica Universitaria de Navarra)
Madrid, Spain · Not yet recruiting
Hospital Universitario Quironsalud Madrid
Madrid, Spain · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.